77: A New Era of Myasthenia Gravis Treatment episode artwork

EPISODE · Nov 18, 2022 · 33 MIN

77: A New Era of Myasthenia Gravis Treatment

from NeurologyLive® Mind Moments® · host NeurologyLive

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this episode, we spoke with George Small, MD, an adult neurologist at Allegheny Health Network, who discussed the state of care for myasthenia gravis and its recent success, the corresponding changes to patient care, and the current era of treatment that the field has entered, among other topics.Looking for more myasthenia gravis discussion? Check out this NeurologyLive® Peers & Perspectives series, featuring James F. Howard Jr., MD, and Nicholas J. Silvestri MD, FAAN: Updates in the Management of Myasthenia Gravis Peers and PerspectivesEpisode Breakdown: 1:15 – The perspective on the current state of care in myasthenia gravis 4:05 – The rapidly evolving treatment landscape 6:40 – Allegheny Health Network's approach to myasthenia gravis care 10:05 – Treatment selection among patient groups 15:45 – Neurology News Minute 18:45 – Current challenges and adjustments with treatments 21:20 – Nonpharmacologic approaches to myasthenia gravis 26:55 – Challenges for patients and education around treatment access 28:35 – The future of myasthenia gravis care This episode is brought to you by the Medical World News streaming service. Check out new content and shows every day, only at medicalworldnews.comThe stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Neurosteer Single-Channel EEG Platform Cleared by FDA Neurocrine Biosciences Submits Supplemental NDA for Valbenazine in the Treatment of Huntington Disease Chorea FDA Refuses to File BrainStorm’s BLA for NurOwn Mesenchymal ALS Therapy FDA Accepts NDA for Parkinson Disease Treatment IPX203 FDA Accepts NDA for Myasthenia Gravis Treatment Zilucoplan Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Episode metadata supplied by the publisher feed · Published Nov 18, 2022

Embed this episode

NOW PLAYING

77: A New Era of Myasthenia Gravis Treatment

0:00 33:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NeurologyLive® Mind Moments®?

This episode is 33 minutes long.

When was this NeurologyLive® Mind Moments® episode published?

This episode was published on November 18, 2022.

Can I download this NeurologyLive® Mind Moments® episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!